QPT — Quest PharmaTech Balance Sheet
0.000.00%
Last trade - 00:00- CA$5.92m
- CA$6.83m
- 32
- 82
- 11
- 36
Annual balance sheet for Quest PharmaTech, fiscal year end - January 31st, CAD millions except per share, conversion factor applied.
2019 January 31st | 2020 January 31st | 2021 January 31st | 2022 January 31st | 2023 January 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 3.46 | 2.45 | 0.199 | 0.264 | 0.375 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.014 | 0.011 | 0.033 | 0 | 0.221 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 4.3 | 2.89 | 0.281 | 0.288 | 0.622 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.02 | 0.099 | 0.055 | 0.016 | 0.003 |
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 5.81 | 4.45 | 176 | 91 | 84.4 |
| Payable / Accrued | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 10.1 | 20.9 | 0.335 | 0.623 | 1.11 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Liabilities | 16.1 | 19.8 | 0.389 | 0.623 | 1.11 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | -10.3 | -15.3 | 175 | 90.4 | 83.3 |
| Total Liabilities & Shareholders' Equity | 5.81 | 4.45 | 176 | 91 | 84.4 |
| Total Common Shares Outstanding |